Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03112928
Other study ID # 007733
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 8, 2017
Est. completion date September 20, 2021

Study information

Verified date September 2020
Source Integrum
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This international, multi-center, double-blind, randomized, controlled clinical trial aims to evaluate the efficacy of Phantom Motor Execution (PME) and Phantom Motor Imagery (PMI) as treatments of Phantom Limb Pain (PLP). In PME, myoelectric pattern recognition (MPR) is used to predict motor volition and then use the decoded movements to control virtual and augmented reality environments (VR/AR), along with serious gaming (SG). The same device and VR/AR environments are used in PMI with the difference that subjects will imagine rather than execute phantom movements. Electromyography is used to monitor for no muscular activity in PMI.


Description:

Sixty-six subjects with upper or lower limb amputations are planned to take part in this study. Subjects will be assigned randomly to PME and PMI treatments (2:1 proportion). After treatment completion (15 sessions of 2 hours each) and follow-up period of six months, patients that received PMI will be given the choice to receive PME. The design is double blinded as the patient will be informed that the treatment received, regardless of which, has been shown effective in previous studies. The person conducting the pain evaluations will be blinded to which treatment each patient receives, and will not take part on providing treatment (evaluator and therapist are different persons).


Recruitment information / eligibility

Status Completed
Enrollment 77
Est. completion date September 20, 2021
Est. primary completion date March 12, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Subject must be older than 18 years. - If the subjects are under pharmacological treatments, there must be no variations on the medicament dosages for at least one month (steady consumption). - The last session of previous treatments must be at least 3 months old. - Any pain reduction potentially attributed to previous phantom limb pain treatments must be at least 3 months old. - Subjects must have control over at least a portion of biceps and triceps muscles for upper limb amputations, and quadriceps and hamstrings for the lower limb amputations. - The subject has signed a written informed consent. - The subject must be in a stable prosthetic situation (i.e. satisfied with the fitting of the prosthesis) or being a non user. - At least six months should be passed since the amputation: acute phantom limb pain cases should not be included in the study. - The patient subject should not have a significant cognitive impairment that prevents the patient from following instructions. - Subjects with abundant soft tissue on their stump will not be automatically excluded, however, an evaluation in the system is required to analyze if sufficient electromyography signals can be recorded. - Subjects for whom skin contact or muscle contraction are painful (NRS > 2) are not eligible for the study. - The subject should not have any condition associated with risk of poor protocol compliance. - The subject should not have any other condition or symptoms preventing the patient from entering the study, according to the investigatorĀ“s judgement.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Phantom Motor Execution
Neuromotus - PME decodes motor volition applying machine learning to surface electromyography. Once the intention of movement is known, this is use to control serious games in virtual and augmented reality. A treatment session of MPE consists of: Pain evaluation Placement of the electrodes and fiducial marker Practice of motor execution in Augmented Reality (AR) Gaming using phantom movements Practice of motor execution by matching random target postures of a virtual limb. Step 3 to 4 are repeated for different phantom joints, initially one at the time progressing to several joints simultaneously. A treatment session last 2 hours.
Phantom Motor Imagery
The only difference between PME and PMI is that in the former myoelectric signals are used to give the participants control over the virtual environments, whereas in PMI the presence of myoelectric activity is used as an alarm to remind the participant that it must imagine rather than execute the phantom movement. In PMI the virtual environments act autonomously to guide the participant in imagination of movement.

Locations

Country Name City State
Canada Institue of Biomedical Engineering, University of New Brunswick Fredericton New Brunswick
Germany Department of Psychosomatic Medicine and Psychotherapy, LWL University Hospital, Ruhr - University Bochum (RUB) Bochum
Ireland School of Psychology, National University of Ireland Galway Connacht
Netherlands University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine Groningen
Slovenia University Rehabilitation Institute Ljubljana
Sweden Gåskolan, Ortopedtekniska avdelningen Göteborg Västergötland
Sweden Ortopedteknik, Region Örebro län Örebro Närke
Sweden Bräcke Diakoni Stockholm Uppland
United States Shirley Ryan Ability Lab Chicago Illinois

Sponsors (11)

Lead Sponsor Collaborator
Integrum Bräcke Diakoni, Sweden, Chalmers University of Technology, National University of Ireland, Galway, Ireland, Örebro University, Sweden, Ruhr University of Bochum, Sahlgrenska University Hospital, Sweden, Shirley Ryan AbilityLab, University Medical Center Groningen, University of New Brunswick, University Rehabilitation Institute, Republic of Slovenia

Countries where clinical trial is conducted

United States,  Canada,  Germany,  Ireland,  Netherlands,  Slovenia,  Sweden, 

References & Publications (2)

Ortiz-Catalan M, Guethmundsdottir RA, Kristoffersen MB, Zepeda-Echavarria A, Caine-Winterberger K, Kulbacka-Ortiz K, Widehammar C, Eriksson K, Stockselius A, Ragno C, Pihlar Z, Burger H, Hermansson L. Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain. Lancet. 2016 Dec 10;388(10062):2885-2894. doi: 10.1016/S0140-6736(16)31598-7. Epub 2016 Dec 2. — View Citation

Ortiz-Catalan M, Sander N, Kristoffersen MB, Hakansson B, Branemark R. Treatment of phantom limb pain (PLP) based on augmented reality and gaming controlled by myoelectric pattern recognition: a case study of a chronic PLP patient. Front Neurosci. 2014 Feb 25;8:24. doi: 10.3389/fnins.2014.00024. eCollection 2014. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Rating Index registered at the beginning (1st session) and at the end of the treatment (15th session). The Pain Rating Index (PRI) is calculated as the sum of 15 descriptors. At the end of each treatment session the descriptors are presented to the patient, who rates each of them with an intensity scale from 0 to 3. The PRI is therefore a number between 0 and 45: the higher the index the greater is the pain. The primary efficacy variable for this study is the change in PRI between the first and the last treatment session. 28-40 weeks, depending on the frequency of the sessions.
Secondary Pain Disability Index registered at the beginning (1st session) and the end of the treatment (15th session). The Pain Disability Index (PDI) measures the impact that pain has on the ability of a person to participate in essential life activities. The index is comprised between 0 and 70. The higher the index the greater the person's disability due to pain is. The secondary efficacy variable of this study is the change in PDI between the first and the last treatment session. 28-40 weeks, depending on the frequency of the sessions.
See also
  Status Clinical Trial Phase
Completed NCT04060875 - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Active, not recruiting NCT02519907 - Surface Electrical Stimulation for Treatment of Phantom Limb Pain N/A
Completed NCT02281539 - Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain N/A
Completed NCT01608035 - Sciatic Perineural Versus Stump Catheter for Below Knee Amputation Phase 0
Completed NCT03111277 - MR Guided Focused Ultrasound for Treatment of Neuropathic Pain N/A
Recruiting NCT05188183 - Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response N/A
Active, not recruiting NCT02221934 - Electrical Nerve Block for Amputation Pain N/A
Active, not recruiting NCT03029884 - Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain N/A
Completed NCT04538417 - C-RFA of Residual Limb Neuroma N/A
Completed NCT03317600 - Postamputation Pain: Peripheral Mechanisms N/A
Completed NCT01996254 - Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System N/A
Terminated NCT00771862 - Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study Phase 4
Completed NCT00462566 - The Efficacy of Motor Cortex Stimulation for Pain Control N/A
Completed NCT05684445 - The Effect of Distant Reiki on Pain and Holistic Well-being N/A
Completed NCT02784548 - Virtual Reality for Phantom Limb Pain N/A
Active, not recruiting NCT05915065 - VR to Evaluate Phantom Limb Pain N/A
Completed NCT00797849 - Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees N/A
Enrolling by invitation NCT05807607 - Study of Lower-limb Phantom Pain Syndrome Using Peripheral Nerve and Spinal Cord Stimulation N/A
Completed NCT03350061 - Prosthesis With Sensations N/A
Active, not recruiting NCT06428123 - Comparison of Efficacy of Mirror Therapy vs Mental Imagery in Reduction of Phantom Limb Pain in AKAP N/A